https://finance.yahoo.com/news/roche-introduce-next-generation-portfolio-050300281.html
0
0
Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional use - Yahoo Finance
10/12/22 at 5:11am
Organization
Yahoo Entertainment
Author
F. Hoffmann-La Roche Ltd
Details
48 words
Summarize
Health Roche Pharmaceuticals & Biotech SARS-CoV CE Mark Yahoo Finance Broad
Broad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights gained throughout the...
Create an account or login to join the discussion